Secondary endpoints: surrogate interest or supplementary table?

The article by Matthews and colleagues (1) emphasizes the potential impending consequences of underreporting secondary endpoints in studies addressing surgical site infection rates. Generally speaking, this may be a very crucial question about clinical trial methodology and rigor.